http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2020011382-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365
filingDate 2019-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ef4ed5dbf7d4c35bacb8d09a3a5722f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e696b95303cd0e19cdb905d41f356d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55181d37a32b6b0a452f5a232b40de44
publicationDate 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2020011382-A
titleOfInvention TETRAHYDROPYRANOXAZINE DERIVATIVES HAVING SELECTIVE BETA-SECRETASE 1 (BACE1) INHIBITOR ACTIVITY.
abstract The present invention provides a compound which has an effect of inhibiting the production of β amyloid, especially an inhibiting effect of BACE1, and which is useful as a therapeutic or prophylactic agent for diseases induced by the production, secretion and/or deposition of β proteins. amyloids. A compound of formula (I) in which R3 is each independently alkyl optionally substituted with halogen, cyano, alkyloxy, haloalkyloxy or non-aromatic carbocyclyl, or the like; t is an integer from 0 to 3; R5 is a hydrogen or halogen atom; R6 is selected from the group consisting of a hydrogen atom, halogen, and substituted or unsubstituted alkyl, Ring B is a substituted or unsubstituted pyrazine or the like, or a pharmaceutically acceptable salt thereof.
priorityDate 2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29392
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419092424
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID585631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152421837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID614333

Total number of triples: 31.